ADVANCE infectious diseases pharmacy and LEAD antimicrobial stewardship in order
to OPTIMIZE the care of patients

  • Home
  • Favipiravir versus arbidol for COVID-19: a randomized clinical trial

Favipiravir versus arbidol for COVID-19: a randomized clinical trial

27 Apr 2020 5:07 PM | Daniel Hawley (Administrator)


Society of Infectious Diseases Pharmacists •  110 E. Schiller St., Suite 230, Elmhurst, IL 60126
(331) 248-7888sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software